quetiapine actiofarma
actiofarma, uab - kvetiapinas - pailginto atpalaidavimo tabletės - 200 mg - quetiapine
valaciclovir actiofarma
actiofarma, uab - valacikloviras - plėvele dengtos tabletės - 1000 mg - valaciclovir
bicalutamide actiofarma
actiofarma, uab - bikalutamidas - plėvele dengtos tabletės - 50 mg - bicalutamide
claritine
actiofarma, uab - loratadinas - tabletės - 10 mg - loratadine
clormetin
actiofarma, uab - chlormadinonas/etinilestradiolis - plėvele dengtos tabletės - 2 mg/0,03 mg - chlormadinone and ethinylestradiol
escitalopram actavis
actiofarma, uab - escitalopramas - plėvele dengta tabletė - 10 mg - escitalopram
gepretix
actiofarma, uab - progesteronas - minkštosios kapsulės - 100 mg; 200 mg - progesterone
nasonex
actiofarma, uab - mometazono furoatas - nosies purškalas (suspensija) - 50 µg/dozėje - mometasone
adrenalina s.a.l.f.
actiofarma, uab - adrenalinas - injekcinis ar infuzinis tirpalas - 1 mg/ml - epinephrine
pluvicto
novartis europharm limited - lutetium (177lu) vipivotide tetraxetan - prostatos navikai, kastracija-atsparus - terapiniai radiofarmaciniai preparatai - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.